Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cebon

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Hybridoma|December 1, 1990
Monoclonal antibodies that recognize human granulocyte-macrophage colony-stimulating factor and neutralize its bioactivity in vitroP J Dempsey, J E Layton, U Duhrsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Comparative study of the pharmacokinetics and toxicity of high-dose epirubicin with or without dexrazoxane in patients with advanced malignancyR L Basser, M M Sobol, G Duggan, et al.
Clinical and Experimental Immunology|December 1, 1995
Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemiaP M Waring, J Presneill, D W Maher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentationT Luft, M Rizkalla, T Y Tai, et al.
Cancer Investigation|January 1, 1989
Early clinical trials with colony-stimulating factorsG Morstyn, G J Lieschke, J Cebon, et al.
Annals of Internal Medicine|March 1, 1989
Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancyG J Lieschke, D Maher, J Cebon, et al.
Growth Factors (Chur, Switzerland)|May 4, 2001
Pharmacokinetic analysis of pegylated megakaryocyte growth and development factor in humansR H De Boer, L K Roskos, E Cheung, et al.
The Journal of Biological Chemistry|March 15, 1990
Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activityJ Cebon, N Nicola, M Ward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancerP L R Mitchell, R Basser, M Chipman, et al.
Tissue Antigens|April 21, 2007
Fourier transform infrared imaging as a method for detection of HLA class I expression in melanoma without the use of antibodyS F Chew, B R Wood, C Kanaan, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Hybridoma|December 1, 1990
Monoclonal antibodies that recognize human granulocyte-macrophage colony-stimulating factor and neutralize its bioactivity in vitroP J Dempsey, J E Layton, U Duhrsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Comparative study of the pharmacokinetics and toxicity of high-dose epirubicin with or without dexrazoxane in patients with advanced malignancyR L Basser, M M Sobol, G Duggan, et al.
Clinical and Experimental Immunology|December 1, 1995
Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemiaP M Waring, J Presneill, D W Maher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentationT Luft, M Rizkalla, T Y Tai, et al.
Cancer Investigation|January 1, 1989
Early clinical trials with colony-stimulating factorsG Morstyn, G J Lieschke, J Cebon, et al.
Annals of Internal Medicine|March 1, 1989
Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancyG J Lieschke, D Maher, J Cebon, et al.
Growth Factors (Chur, Switzerland)|May 4, 2001
Pharmacokinetic analysis of pegylated megakaryocyte growth and development factor in humansR H De Boer, L K Roskos, E Cheung, et al.
The Journal of Biological Chemistry|March 15, 1990
Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activityJ Cebon, N Nicola, M Ward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancerP L R Mitchell, R Basser, M Chipman, et al.
Tissue Antigens|April 21, 2007
Fourier transform infrared imaging as a method for detection of HLA class I expression in melanoma without the use of antibodyS F Chew, B R Wood, C Kanaan, et al.
Pageof 7